Skip to main content
. Author manuscript; available in PMC: 2008 Sep 11.
Published in final edited form as: J Med Chem. 2007 Mar 21;50(8):1828–1839. doi: 10.1021/jm061304k

Table 6.

In vitro anti-HIV-1 activity of d-3′-F-C-d4G against wild type (WT) and M184V virus in human PBM cells using carbovir as positive control and correlation with calculated energy of complex (Inhibitor-TP) / HIV-RT after molecular dynamics simulations.

Compound xxBRU (WT) M184V FIb ΔErelc
EC50
(μM)
Erela
(Kcal/mol)
EC50
(μM)
Erela
(Kcal/mol)
d-3′-F-C-d4G 35 0.098 -270.2d 3.8 84.9d 38.8 -355.1d
Carbovir 0.087 -310.0d 0.20 -63.4d 2.3 -246.6d
a

Erel = (Binding energy of inhibitor-TP) – (Binding energy of natural 2′-dNTP)

b

FI is the Fold Increase (EC50 HIV-1M184V / EC50 HIV-1xxBRU).

c

ΔErel = Erel (WT) – Erel (M184V).

d

These values were calculated based on the molecular dynamics results (refer to experimental section)